Resources from the same session
5959 - Efficacy Evaluation of Optimal Patient Selection for Hypopharyngeal Cancer Organ Preservation Therapy using MRI-derived Radiomic Signature: Bi-institutional Propensity Score Matched Analysis
Presenter: Shih-min Lin
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
3107 - Survival and prognostic factors of nasopharyngeal cancer patients in non-endemic countries: a large multicentric database analysis
Presenter: Paolo Bossi
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
2016 - High Immunoscore is associated with good response to neo-adjuvant chemotherapy and prolonged survival in advanced Head and Neck cancer patients.
Presenter: Haitham Mirghani
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
2603 - Analysis of Efficacy Outcomes Based on Programmed Death Ligand 1 (PD-L1) Scoring Techniques in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) From KEYNOTE-040
Presenter: Ezra Cohen
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
4782 - A window of opportunity trial of preoperative nivolumab with or without tadalafil in squamous cell carcinoma of the head and neck (SCCHN): safety, clinical, and correlative outcomes
Presenter: Adam Luginbuhl
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
2557 - Pembrolizumab and radiotherapy for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) with contraindication to cisplatin therapy
Presenter: Siddharth Sheth
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
4934 - Avelumab-cetuximab-radiotherapy versus standards of care (SoC) in patients (pts) with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): safety phase of randomized trial GORTEC 2017-01 (REACH)
Presenter: Yungan Tao
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
4541 - Inducible T cell Costimulatory (ICOS) Receptor Agonist, GSK3359609 (GSK609) alone and in combination with Pembrolizumab (pembro): preliminary results from INDUCE-1 expansion cohorts (EC) in Head and Neck Squamous Cell Carcinoma (HNSCC)
Presenter: Danny Rischin
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
3463 - Buparlisib (BKM120) in refractory head and neck squamous cell carcinoma harbouring or not a PI3KCA mutation: a phase II multicenter trial
Presenter: Jérome Fayette
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
Poster Discussion – Head and neck cancer - Invited Discussant 1112PD, 1113PD and 1114PD
Presenter: Laura Locati
Session: Poster Discussion – Head and neck cancer
Resources:
Slides
Webcast